Detalhe da pesquisa
1.
Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients.
J Transl Med
; 16(1): 251, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30189880
2.
Synthesis and Characterization of Specific Reverse Transcriptase Inhibitors for Mammalian LINE-1 Retrotransposons.
Cell Chem Biol
; 26(8): 1095-1109.e14, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155508
3.
A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs.
Oncotarget
; 8(41): 70472-70480, 2017 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29050295
4.
Dormant Circulating Tumor Cells in Prostate Cancer: Therapeutic, Clinical and Biological Implications.
Curr Drug Targets
; 17(6): 693-701, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25751007
5.
Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC).
Surgery
; 159(3): 728-35, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26518392
6.
miRNA in situ hybridization in circulating tumor cells--MishCTC.
Sci Rep
; 5: 9207, 2015 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25777797
7.
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer.
Oncotarget
; 5(17): 7486-97, 2014 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25277187